Nerve Block for Subarachnoid Hemorrhage (BLOCK-SAH Trial)

"According to the latest report on clinicaltrials.gov, this medical trial is actively inviting volunteers with its inception date set at November 27th 2023 and last edited on November 29th of the same year."

"Affirmative, the information accessible on clinicaltrials.gov confirms that this trial is actively searching for participants; it was initially posted in November of 2023 and most recently updated a couple days later. 195 patients must be recruited from one medical centre."

"According to the eligibility requirements, individuals aged between 18 and 85 can enter in this trial. Moreover, 66 clinical trials are available for people under 18 years old while 387 are tailored towards those over 65."

"The safety of Group 1 - Active was estimated at 2, since there is some data verifying its safe use but no evidence pointing to a potential efficacy."

"This clinical trial is open to 195 participants who have been diagnosed with headache; they must be between the ages of 18 and 85. In order to qualify, individuals must provide signed consent, agree to abide by study requirements for duration of investigation, identify as male or female, possess a SAH diagnosis within 48 hours from ictus hemorrhage, demonstrate modified Fisher grade 1-4 (on admission imaging), Hunt and Hess 1-3 or World Federation of Neurosurgeons grade 1-4 (on admission if additionally meeting Glasgow Coma Scale verbal subscore ≥ 4 criteria), indicate minimum Glasgow Coma Scale verbal subscore of 4 on screening"